rs3828472

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000844.4(GRM7):​c.520-133A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 683,554 control chromosomes in the GnomAD database, including 25,612 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 4901 hom., cov: 32)
Exomes 𝑓: 0.27 ( 20711 hom. )

Consequence

GRM7
NM_000844.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.44

Publications

10 publications found
Variant links:
Genes affected
GRM7 (HGNC:4599): (glutamate metabotropic receptor 7) L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
GRM7 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.296 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRM7NM_000844.4 linkc.520-133A>C intron_variant Intron 1 of 9 ENST00000357716.9 NP_000835.1 Q14831-1B2R693Q59G95

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRM7ENST00000357716.9 linkc.520-133A>C intron_variant Intron 1 of 9 1 NM_000844.4 ENSP00000350348.4 Q14831-1
GRM7ENST00000440923.7 linkn.520-133A>C intron_variant Intron 1 of 11 2 ENSP00000412329.3 H7C3K2

Frequencies

GnomAD3 genomes
AF:
0.242
AC:
36794
AN:
152022
Hom.:
4905
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.153
Gnomad AMI
AF:
0.345
Gnomad AMR
AF:
0.179
Gnomad ASJ
AF:
0.303
Gnomad EAS
AF:
0.178
Gnomad SAS
AF:
0.229
Gnomad FIN
AF:
0.322
Gnomad MID
AF:
0.237
Gnomad NFE
AF:
0.300
Gnomad OTH
AF:
0.234
GnomAD4 exome
AF:
0.272
AC:
144515
AN:
531414
Hom.:
20711
AF XY:
0.272
AC XY:
76381
AN XY:
281264
show subpopulations
African (AFR)
AF:
0.157
AC:
2329
AN:
14790
American (AMR)
AF:
0.147
AC:
4181
AN:
28442
Ashkenazi Jewish (ASJ)
AF:
0.305
AC:
4782
AN:
15690
East Asian (EAS)
AF:
0.149
AC:
4917
AN:
33060
South Asian (SAS)
AF:
0.227
AC:
12262
AN:
53944
European-Finnish (FIN)
AF:
0.312
AC:
12191
AN:
39048
Middle Eastern (MID)
AF:
0.254
AC:
545
AN:
2148
European-Non Finnish (NFE)
AF:
0.303
AC:
95505
AN:
315342
Other (OTH)
AF:
0.270
AC:
7803
AN:
28950
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
5365
10730
16096
21461
26826
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
754
1508
2262
3016
3770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.242
AC:
36797
AN:
152140
Hom.:
4901
Cov.:
32
AF XY:
0.241
AC XY:
17917
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.153
AC:
6356
AN:
41532
American (AMR)
AF:
0.178
AC:
2726
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.303
AC:
1051
AN:
3468
East Asian (EAS)
AF:
0.178
AC:
919
AN:
5166
South Asian (SAS)
AF:
0.230
AC:
1109
AN:
4824
European-Finnish (FIN)
AF:
0.322
AC:
3405
AN:
10584
Middle Eastern (MID)
AF:
0.231
AC:
68
AN:
294
European-Non Finnish (NFE)
AF:
0.300
AC:
20356
AN:
67962
Other (OTH)
AF:
0.233
AC:
492
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1434
2868
4302
5736
7170
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
390
780
1170
1560
1950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.279
Hom.:
25677
Bravo
AF:
0.225
Asia WGS
AF:
0.229
AC:
796
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.054
DANN
Benign
0.51
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3828472; hg19: chr3-7188006; API